Alpine Associates Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Alpine Associates Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,086,227	Closed	-$58.2M	–	66
2019 Q3	$58.2M	Buy	+3,086,227	New	+$35.3M	1.91%	20

Alpine Associates Management's ALDR Position: Q4 2019 in Review

Alpine Associates Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 3,086,227 shares — an estimated $58.2M sold.

Alpine Associates Management first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $58.2M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Alpine Associates Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Alpine Associates Management sold 3,086,227 Alder Biopharmaceuticals shares in Q4 2019, an estimated $58.2M.
Alpine Associates Management first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Alpine Associates Management's Alder Biopharmaceuticals position peaked at $58.2M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Alpine Associates Management's 13F filing for Q4 2019, filed 13 Feb 2020.